Opinion|Videos|June 12, 2024
Cost, Value, and Affordability of Treatment for Alzheimer Disease
A comprehensive discussion on the value of therapies for Alzheimer disease based on cost vs outcome, and unmet needs in the overall treatment landscape.
Advertisement
Video content above is prompted by the following question(s):
- Could you describe drug cost versus value versus affordability?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- AML Survival After 3 Years in Remission Comparable With General Population
September 20th 2025
- CSU More Burdensome in Female Patients, Especially in Midlife
September 20th 2025
- Rocatinlimab AD Combo Therapy Safe, Effective Over 24 Weeks
September 19th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Rural-Urban Disparities in Colorectal Cancer Screening Persist
2
Insurance Coverage Improves for Same-Sex Couples, Yet Disparities Persist
3
Medicaid Work Rules Could Strain Hospitals: Laxmi Patel
4
Identifying Barriers to Colorectal Cancer Screening for People With IDD
5